ORI Healthcare Fund invests $18 mln in genetic cancer test startup Pillar Biosciences
ORI Healthcare Fund L.P. completed an $18 million investment into Boston-based Pillar Biosciences Inc., a genetic oncology testing start-up. The investment will be used to continue R&D into tumor tissue analytics and to add liquid biopsy products.
11 May 2016•2 mins read
